Cinven to quintuple its money with AMCo sale

Cinven Partners LLP expects to make 5x its investment with the $3.5 billion sale of Amdipharm Mercury Ltd to Concorida Healthcare, Buyouts has learned.

8 September 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail